October 21, 2021
Currax Pharmaceuticals Granted Type C Meeting with FDA Regarding its Phase 3 Study to Evaluate the Safety and Efficacy of CX-101
Read moreSeptember 30, 2021
Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters
Read moreAugust 2, 2021
Currax Pharmaceuticals Moves Global Headquarters to Brentwood, Tennessee
Read moreJune 25, 2021
Currax Launches Why Weight: Communicate Initiative to Encourage Conversations about Weight Loss
Read moreFebruary 27, 2020
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
Read moreSeptember 27, 2019
Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Read moreSeptember 26, 2019
Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®
Read moreMay 1, 2019